TGen licenses first drug for patient use in clinical care
Wednesday, May 4, 2011 - 14:00
in Health & Medicine
The Translational Genomics Research Institute (TGen) has licensed its first drug, a unique compound that targets cancer tumors by modifying the actions of proteins.